Human growth hormone (somatropin) in adults with growth hormone deficiency

TA64 Growth hormone deficiency (adults) - human growth hormone: summary

Growth hormone deficiency (adults) - human growth hormone: review decision - november 2014 information

Appendix A: Decision paper presented to the Institute’s Guidance Executive

Growth hormone deficiency (adults) - human growth hormone: appendix a - ge decision paper - november 2014 (PDF 109 KB)

Growth hormone deficiency (adults) - human growth hormone: appendix a - ge decision paper - november 2014

Growth hormone deficiency (adults) - human growth hormone: appendix a - ge decision paper - november 2014 (PDF 109 KB)

Growth hormone deficiency (adults) - human growth hormone: Review proposal September 2014 information

Growth hormone deficiency (adults) - human growth hormone: Appendix A provisional matrix of stakeholders

Growth hormone deficiency (adults) - human growth hormone: Appendix A provisional matrix of stakeholders (PDF 36 KB)

Growth hormone deficiency (adults) - human growth hormone: Appendix B proposal paper presented to the Institute?s Guidance Executive

Growth hormone deficiency (adults) - human growth hormone: Appendix B proposal paper presented to the Institute?s Guidance Executive (PDF 333 KB)

Review update: May 2012 information

Review decision - June 2009 information

A link to the summary of the responses from this consultation

Review decision - June 2009: appendix 1 - proposal comment summary table (PDF 27 KB)

Review proposal: May 2009 information

Review proposal: May 2009, Appendix A - provisional matrix

Review proposal: May 2009, Appendix A - provisional matrix (PDF 33 KB)

Review decison information

Review proposal information

Clinical and cost effectiveness of recombinant human growth hormone (Somatropin) in adults: report by a consortium from the School of Health and Related Research (ScHARR), University of Sheffield

Clinical and cost effectiveness of recombinant human growth hormone (Somatropin) in adults: report by a consortium from the School of Health and Related Research (ScHARR), University of Sheffield (PDF 567 KB)

Decision of the appeal panel: appraisal of the use of human growth hormone for the treatment of adults with growth hormone deficiency

Decision of the appeal panel: appraisal of the use of human growth hormone for the treatment of adults with growth hormone deficiency (PDF 122 KB)

Questionnaire: quality of life - assessment of deficiency in adults information

Questionnaire: quality of life - assessment of deficiency in adults (PDF 841 KB)

Review decision - June 2009: appendix 1 - proposal comment summary table

Growth hormone deficiency (adults) - human growth hormone - Appeal Decision

Final Appraisal Determination: Human growth hormone (somatropin) in adults with growth hormone deficiency information

ScHARR response to the post appeal considerations for the clinical and cost effectiveness of human growth hormone (Somatropin) in adults

Human growth hormone appeal panel decision  information

Post Appeal Consideration